Ignite Creation Date:
2025-12-25 @ 1:38 AM
Ignite Modification Date:
2025-12-27 @ 11:00 PM
Study NCT ID:
NCT05736094
Status:
COMPLETED
Last Update Posted:
2024-04-05
First Post:
2023-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ultrasound for Detection of Prostate Cancer
Sponsor:
Oslo University Hospital
Organization:
Study Overview
Official Title:
Dual-frequency Ultrasound for Detection of Prostate Cancer
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SURF
Brief Summary:
Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.
Detailed Description:
Prospectively recruited patients before prostatectomy and/or definitive radiotherapy will be included in the study. Dual-frequency ultrasound imaging will be compared to standard transrectal ultrasound and MRI. Imaging of primary tumor with dual-frequency ultrasound technology including the use of microbubble contrast-media.
A prostate biopsy and blood sample will be taken from each patient, for histopathology and explorative biomarkers.
A prostate biopsy and blood sample will be taken from each patient, for histopathology and explorative biomarkers.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 313778 | OTHER_GRANT | The Research Council of Norway | View |